Results for "Specialty Pharmaceutical Distribution Facts, Figures, and Trends"
HDA Statement on the Confirmation of Robert F. Kennedy, Jr. As HHS Secretary
HDA released a statement on the confirmation of Robert F. Kennedy, Jr., to lead the U.S. Department of Health and Human Services.
HDA Responds to the FTC/HHS Request for Information on Drug Shortages
The Healthcare Distribution Alliance (HDA) submitted comments to the Department of Health and Human Services (HHS) and the Federal Trade Commission (FTC) in response to the agencies’ joint Request for Information (RFI) on “Solicitation for Public Comment to Understand Lack of Competition and Contracting Practices that May be Contributing to Drug Shortages.”
Distributors Leading Efforts to Maintain Supply Chain Integrity
While the impact of the COVID-19 pandemic continues to unfold, distributors are taking proactive steps and working closely with the broader healthcare community to respond to the crisis and prevent disruptions to the pharmaceutical supply chain. As the logistics experts of healthcare, our commitment is to ensure that providers, pharmacies and the patients they serve have access to the vital medicines and supplies they need during these challenging times.
HDA Statement on PREVENT Pandemics Act
The Healthcare Distribution Alliance (HDA) released a statement on the inclusion of the PREVENT Pandemics Act (Prepare for a Respond to Existing Viruses, Emerging New Threats, and Pandemics Act), as part of the Consolidated Appropriations Act.